{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T17:01:03Z","timestamp":1781283663013,"version":"3.54.1"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,7]],"date-time":"2023-03-07T00:00:00Z","timestamp":1678147200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010002","name":"Ministry of Education","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC111-2321-B-A49-007-"],"award-info":[{"award-number":["NSTC111-2321-B-A49-007-"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010101","name":"Taichung Veterans General Hospital","doi-asserted-by":"publisher","award":["TCVGH-1114401C"],"award-info":[{"award-number":["TCVGH-1114401C"]}],"id":[{"id":"10.13039\/501100010101","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011913","name":"Kaohsiung Veterans General Hospital","doi-asserted-by":"publisher","award":["TCVGH-11144002D"],"award-info":[{"award-number":["TCVGH-11144002D"]}],"id":[{"id":"10.13039\/501100011913","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.biopha.2023.114481","type":"journal-article","created":{"date-parts":[[2023,3,10]],"date-time":"2023-03-10T02:28:30Z","timestamp":1678415310000},"page":"114481","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Ovatodiolide inhibits SARS-CoV-2 replication and ameliorates pulmonary fibrosis through suppression of the TGF-\u03b2\/T\u03b2Rs signaling pathway"],"prefix":"10.1016","volume":"161","author":[{"given":"Wei-Chung","family":"Chiou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guan-Jhong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7731-8493","authenticated-orcid":false,"given":"Tein-Yao","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tzu-Lan","family":"Hsia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao-You","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jir-Mehng","family":"Lo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pin-Kuei","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8220-1815","authenticated-orcid":false,"given":"Cheng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.biopha.2023.114481_bib1","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/s41564-020-0695-z","article-title":"The species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2","volume":"5","author":"Coronaviridae Study Group of the International Committee on Taxonomy of","year":"2020","journal-title":"Nat. Microbiol."},{"issue":"12","key":"10.1016\/j.biopha.2023.114481_bib2","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.it.2020.10.004","article-title":"Mechanisms of SARS-CoV-2 transmission and pathogenesis","volume":"41","author":"Harrison","year":"2020","journal-title":"Trends Immunol."},{"issue":"23","key":"10.1016\/j.biopha.2023.114481_bib3","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMra2026131","article-title":"Cytokine storm","volume":"383","author":"Fajgenbaum","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.biopha.2023.114481_bib4","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1038\/s41591-022-01840-0","article-title":"Long COVID after breakthrough SARS-CoV-2 infection","volume":"28","author":"Al-Aly","year":"2022","journal-title":"Nat. Med."},{"issue":"5","key":"10.1016\/j.biopha.2023.114481_bib5","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/s41569-021-00640-2","article-title":"Potential long-term effects of SARS-CoV-2 infection on the pulmonary vasculature: a global perspective","volume":"19","author":"Halawa","year":"2022","journal-title":"Nat. Rev. Cardiol."},{"issue":"7816","key":"10.1016\/j.biopha.2023.114481_bib6","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/s41586-020-2286-9","article-title":"SARS-CoV-2 protein interaction map reveals targets for drug repurposing","volume":"583","author":"Gordon","year":"2020","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.biopha.2023.114481_bib7","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/s41392-021-00733-x","article-title":"Therapeutic targets and interventional strategies in COVID-19: mechanisms and clinical studies","volume":"6","author":"Zhou","year":"2021","journal-title":"Signal Transduct. Target Ther."},{"issue":"1","key":"10.1016\/j.biopha.2023.114481_bib8","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1186\/s12967-021-03159-9","article-title":"Virus infection induced pulmonary fibrosis","volume":"19","author":"Huang","year":"2021","journal-title":"J. Transl. Med."},{"issue":"2","key":"10.1016\/j.biopha.2023.114481_bib9","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/mi.2008.85","article-title":"Pulmonary fibrosis: pathogenesis, etiology and regulation","volume":"2","author":"Wilson","year":"2009","journal-title":"Mucosal Immunol."},{"issue":"7860","key":"10.1016\/j.biopha.2023.114481_bib10","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/s41586-021-03475-6","article-title":"The spatial landscape of lung pathology during COVID-19 progression","volume":"593","author":"Rendeiro","year":"2021","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.biopha.2023.114481_bib11","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S2213-2600(20)30225-3","article-title":"Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy","volume":"8","author":"George","year":"2020","journal-title":"Lancet Respir. Med."},{"issue":"8","key":"10.1016\/j.biopha.2023.114481_bib12","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/S2213-2600(20)30222-8","article-title":"Pulmonary fibrosis secondary to COVID-19: a call to arms?","volume":"8","author":"Spagnolo","year":"2020","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.biopha.2023.114481_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2019.152840","article-title":"Ovatodiolide inhibits the oncogenicity and cancer stem cell-like phenotype of glioblastoma cells, as well as potentiate the anticancer effect of temozolomide","volume":"61","author":"Su","year":"2019","journal-title":"Phytomedicine"},{"issue":"1","key":"10.1016\/j.biopha.2023.114481_bib14","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1080\/14756366.2020.1850710","article-title":"Repurposing existing drugs: identification of SARS-CoV-2 3C-like protease inhibitors","volume":"36","author":"Chiou","year":"2021","journal-title":"J. Enzym. Inhib. Med. Chem."},{"issue":"D1","key":"10.1016\/j.biopha.2023.114481_bib15","doi-asserted-by":"crossref","first-page":"D1388","DOI":"10.1093\/nar\/gkaa971","article-title":"PubChem in 2021: new data content and improved web interfaces","volume":"49","author":"Kim","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.biopha.2023.114481_bib16","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1758-2946-3-33","article-title":"Open Babel: an open chemical toolbox","volume":"3","author":"O'Boyle","year":"2011","journal-title":"J. Cheminf."},{"issue":"7811","key":"10.1016\/j.biopha.2023.114481_bib17","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41586-020-2223-y","article-title":"Structure of M(pro) from SARS-CoV-2 and discovery of its inhibitors","volume":"582","author":"Jin","year":"2020","journal-title":"Nature"},{"issue":"Suppl 1","key":"10.1016\/j.biopha.2023.114481_bib18","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1186\/1471-2105-12-S1-S33","article-title":"iGEMDOCK: a graphical environment of enhancing GEMDOCK using pharmacological interactions and post-screening analysis","volume":"12","author":"Hsu","year":"2011","journal-title":"BMC Bioinforma."},{"issue":"1","key":"10.1016\/j.biopha.2023.114481_bib19","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1021\/acsnano.0c07383","article-title":"Uncovering flexible active site conformations of SARS-CoV-2 3CL proteases through protease pharmacophore clusters and COVID-19 drug repurposing","volume":"15","author":"Pathak","year":"2021","journal-title":"ACS Nano"},{"key":"10.1016\/j.biopha.2023.114481_bib20","first-page":"583","article-title":"Highly accurate protein structure prediction with AlphaFold","volume":"596","author":"Jumper","year":"2021"},{"issue":"2","key":"10.1016\/j.biopha.2023.114481_bib21","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.cellsig.2011.09.027","article-title":"Structural basis for specificity of TGFbeta family receptor small molecule inhibitors","volume":"24","author":"Ogunjimi","year":"2012","journal-title":"Cell Signal"},{"issue":"Pt 5","key":"10.1016\/j.biopha.2023.114481_bib22","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1107\/S2059798316003624","article-title":"Crystal structures of apo and inhibitor-bound TGFbetaR2 kinase domain: insights into TGFbetaR isoform selectivity","volume":"72","author":"Tebben","year":"2016","journal-title":"Acta Crystallogr. D Struct. Biol."},{"key":"10.1016\/j.biopha.2023.114481_bib23","article-title":"SiMMap: a web server for inferring site-moiety map to recognize interaction preferences between protein pockets and compound moieties","volume":"38","author":"Chen","year":"2010"},{"issue":"17","key":"10.1016\/j.biopha.2023.114481_bib24","doi-asserted-by":"crossref","first-page":"4643","DOI":"10.1093\/bioinformatics\/btaa485","article-title":"UniRule: a unified rule resource for automatic annotation in the UniProt Knowledgebase","volume":"36","author":"MacDougall","year":"2020","journal-title":"Bioinformatics"},{"key":"10.1016\/j.biopha.2023.114481_bib25","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.720018","article-title":"Ugonin J acts as a SARS-CoV-2 3C-like protease inhibitor and exhibits anti-inflammatory properties","volume":"12","author":"Chiou","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.biopha.2023.114481_bib26","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/bph.14859","article-title":"Delayed intervention with a novel SGLT2 inhibitor NGI001 suppresses diet-induced metabolic dysfunction and non-alcoholic fatty liver disease in mice","volume":"177","author":"Chiang","year":"2020","journal-title":"Br. J. Pharmacol."},{"issue":"7","key":"10.1016\/j.biopha.2023.114481_bib27","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: an open-source platform for biological-image analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat. Methods"},{"issue":"9","key":"10.1016\/j.biopha.2023.114481_bib28","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1093\/bioinformatics\/btv746","article-title":"Robust quantitative scratch assay","volume":"32","author":"Vargas","year":"2016","journal-title":"Bioinformatics"},{"issue":"9","key":"10.1016\/j.biopha.2023.114481_bib29","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1021\/ci200060s","article-title":"SHAFTS: a hybrid approach for 3D molecular similarity calculation. 1. Method and assessment of virtual screening","volume":"51","author":"Liu","year":"2011","journal-title":"J. Chem. Inf. Model"},{"issue":"6489","key":"10.1016\/j.biopha.2023.114481_bib30","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1126\/science.abb3405","article-title":"Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved alpha-ketoamide inhibitors","volume":"368","author":"Zhang","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.biopha.2023.114481_bib31","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.bbrc.2020.12.106","article-title":"The inhibitory effects of PGG and EGCG against the SARS-CoV-2 3C-like protease","volume":"591","author":"Chiou","year":"2022","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"26","key":"10.1016\/j.biopha.2023.114481_bib32","doi-asserted-by":"crossref","first-page":"6243","DOI":"10.1016\/j.cell.2021.11.033","article-title":"SARS-CoV-2 infection triggers profibrotic macrophage responses and lung fibrosis","volume":"184","author":"Wendisch","year":"2021","journal-title":"Cell"},{"issue":"3727","key":"10.1016\/j.biopha.2023.114481_bib33","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1126\/science.152.3727.1335","article-title":"Formation of hydroxyproline in collagen","volume":"152","author":"Udenfriend","year":"1966","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.biopha.2023.114481_bib34","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1189\/jlb.1204697","article-title":"Myeloperoxidase: friend and foe","volume":"77","author":"Klebanoff","year":"2005","journal-title":"J. Leukoc. Biol."},{"issue":"4","key":"10.1016\/j.biopha.2023.114481_bib35","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.coph.2009.04.008","article-title":"Anti-inflammatory and pro-inflammatory roles of TGF-beta, IL-10, and IL-22 in immunity and autoimmunity","volume":"9","author":"Sanjabi","year":"2009","journal-title":"Curr. Opin. Pharmacol."},{"issue":"2","key":"10.1016\/j.biopha.2023.114481_bib36","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/AIA.0b013e318034194e","article-title":"Cytokines, inflammation, and pain","volume":"45","author":"Zhang","year":"2007","journal-title":"Int. Anesth. Clin."},{"issue":"7","key":"10.1016\/j.biopha.2023.114481_bib37","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.tcb.2016.03.007","article-title":"Force matters: biomechanical regulation of cell invasion and migration in disease","volume":"26","author":"Kai","year":"2016","journal-title":"Trends Cell Biol."},{"issue":"3","key":"10.1016\/j.biopha.2023.114481_bib38","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20190103","article-title":"Transforming growth factor-beta in tissue fibrosis","volume":"217","author":"Frangogiannis","year":"2020","journal-title":"J. Exp. Med."},{"issue":"5","key":"10.1016\/j.biopha.2023.114481_bib39","first-page":"1257","article-title":"The roles of the myofibroblast in idiopathic pulmonary fibrosis. Ultrastructural and immunohistochemical features of sites of active extracellular matrix synthesis","volume":"138","author":"Kuhn","year":"1991","journal-title":"Am. J. Pathol."},{"issue":"3","key":"10.1016\/j.biopha.2023.114481_bib40","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1513\/pats.200708-146DR","article-title":"Biology of fibroblasts and myofibroblasts","volume":"5","author":"Phan","year":"2008","journal-title":"Proc. Am. Thorac. Soc."},{"issue":"1","key":"10.1016\/j.biopha.2023.114481_bib41","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/s42003-022-03090-9","article-title":"Identification of SARS-CoV-2 inhibitors targeting Mpro and PLpro using in-cell-protease assay","volume":"5","author":"Narayanan","year":"2022","journal-title":"Commun. Biol."},{"issue":"15","key":"10.1016\/j.biopha.2023.114481_bib42","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2119893119","article-title":"COVID-19 therapeutics: challenges and directions for the future","volume":"119","author":"Robinson","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"12","key":"10.1016\/j.biopha.2023.114481_bib43","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1136\/thoraxjnl-2021-217031","article-title":"Pulmonary fibrosis 4 months after COVID-19 is associated with severity of illness and blood leucocyte telomere length","volume":"76","author":"McGroder","year":"2021","journal-title":"Thorax"},{"key":"10.1016\/j.biopha.2023.114481_bib44","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.trsl.2021.09.001","article-title":"From ARDS to pulmonary fibrosis: the next phase of the COVID-19 pandemic?","volume":"241","author":"Michalski","year":"2022","journal-title":"Transl. Res."},{"issue":"6","key":"10.1016\/j.biopha.2023.114481_bib45","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1007\/s10787-022-01027-6","article-title":"Pirfenidone and post-Covid-19 pulmonary fibrosis: invoked again for realistic goals","volume":"30","author":"Al-Kuraishy","year":"2022","journal-title":"Inflammopharmacology"},{"issue":"3","key":"10.1016\/j.biopha.2023.114481_bib46","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1002\/jcp.20972","article-title":"Therapies for bleomycin induced lung fibrosis through regulation of TGF-beta1 induced collagen gene expression","volume":"211","author":"Cutroneo","year":"2007","journal-title":"J. Cell Physiol."},{"issue":"6","key":"10.1016\/j.biopha.2023.114481_bib47","article-title":"The IL-1beta, IL-6, and TNF cytokine triad is associated with post-acute sequelae of COVID-19","volume":"3","author":"Schultheiss","year":"2022","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.biopha.2023.114481_bib48","doi-asserted-by":"crossref","DOI":"10.1007\/s12016-021-08848-3","article-title":"A review of persistent post-COVID syndrome (PPCS)","author":"Oronsky","year":"2021","journal-title":"Clin. Rev. Allergy Immunol."},{"issue":"3","key":"10.1016\/j.biopha.2023.114481_bib49","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.biocel.2007.08.016","article-title":"Progressive pulmonary fibrosis is mediated by TGF-beta isoform 1 but not TGF-beta3","volume":"40","author":"Ask","year":"2008","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"10","key":"10.1016\/j.biopha.2023.114481_bib50","doi-asserted-by":"crossref","first-page":"3675","DOI":"10.1172\/JCI94624","article-title":"Fibroblast-specific inhibition of TGF-beta1 signaling attenuates lung and tumor fibrosis","volume":"127","author":"Wei","year":"2017","journal-title":"J. Clin. Investig."},{"issue":"11","key":"10.1016\/j.biopha.2023.114481_bib51","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1056\/NEJMc1915189","article-title":"Reversal of TGFbeta1-driven profibrotic state in patients with pulmonary fibrosis","volume":"382","author":"Chapman","year":"2020","journal-title":"N. Engl. J. Med"},{"issue":"18","key":"10.1016\/j.biopha.2023.114481_bib52","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1091\/mbc.E17-11-0642","article-title":"A Rnd3\/p190RhoGAP pathway regulates RhoA activity in idiopathic pulmonary fibrosis fibroblasts","volume":"29","author":"Monaghan-Benson","year":"2018","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.biopha.2023.114481_bib53","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/2045-3701-2-9","article-title":"Regulation of TGF-beta receptor activity","volume":"2","author":"Huang","year":"2012","journal-title":"Cell Biosci."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333222300269X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333222300269X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T16:32:59Z","timestamp":1781281979000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S075333222300269X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":53,"alternative-id":["S075333222300269X"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2023.114481","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ovatodiolide inhibits SARS-CoV-2 replication and ameliorates pulmonary fibrosis through suppression of the TGF-\u03b2\/T\u03b2Rs signaling pathway","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2023.114481","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"114481"}}